BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nie Z, Vahdani Y, Cho WC, Bloukh SH, Edis Z, Haghighat S, Falahati M, Kheradmandi R, Jaragh-alhadad LA, Sharifi M. 5-Fluorouracil-containing inorganic iron oxide/platinum nanozymes with dual drug delivery and enzyme-like activity for the treatment of breast cancer. Arabian Journal of Chemistry 2022;15:103966. [DOI: 10.1016/j.arabjc.2022.103966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Valencia-Lazcano AA, Hassan D, Pourmadadi M, Shamsabadipour A, Behzadmehr R, Rahdar A, Medina DI, Díez-Pascual AM. 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy. Eur J Med Chem 2023;246:114995. [PMID: 36493619 DOI: 10.1016/j.ejmech.2022.114995] [Reference Citation Analysis]
2 Yu Y, Zhao W, Yuan X, Li R. Progress and prospects of nanozymes for enhanced antitumor therapy. Front Chem 2022;10. [DOI: 10.3389/fchem.2022.1090795] [Reference Citation Analysis]
3 Zimina TM, Sitkov NO, Gareev KG, Fedorov V, Grouzdev D, Koziaeva V, Gao H, Combs SE, Shevtsov M. Biosensors and Drug Delivery in Oncotheranostics Using Inorganic Synthetic and Biogenic Magnetic Nanoparticles. Biosensors 2022;12:789. [DOI: 10.3390/bios12100789] [Reference Citation Analysis]
4 Halder J, Pradhan D, Biswasroy P, Rai VK, Kar B, Ghosh G, Rath G. Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer. J Drug Target 2022;:1-21. [PMID: 35786242 DOI: 10.1080/1061186X.2022.2095389] [Reference Citation Analysis]